Consultant Cardiologist | Heart Center 🇩🇪 @UniklinikBonn | Clinician Scientist | Project Leader @trr259 | Editorial Board Member @BMC_series
Joined March 2020
- Tweets 473
- Following 1,207
- Followers 1,479
- Likes 2,234
156 Photos and videos
Pinned Tweet
6 Jun 2025
Our latest publication @JAHA_AHA investigating the prevalence, impact & strategies for severe multiple valvular heart disease #MVHD in #TAVR:
Severe #MR & #TR were prevalent & associated with incr. mortality. Staged #TEER reduced 1- & 5-year mortality
➡️bit.ly/4jH2S0p
1
6
1,451
21 Jul 2025
Our latest publication @ejhg_journal on the #genetic architecture of #bicuspid aortic valve (#BAV):
Only ~2% of sporadic #BAV patients carry predicted deleterious rare variants in monogenic #BAV genes, suggesting that most #BAV cases are polygenic.
bit.ly/4nV9iwB
1
2
10
463
Baravan Al-Kassou | MD retweeted
24 Jun 2025
先日のパリ学会中でのインタビュー
JACC cardio. Intervention に掲載された論文の事なんですが、
実は学会で場所が無く、静かな場所を求めて、急遽知人のホテルに転がり込ませてもらって収録した一本
23 Jun 2025
What are the outcomes of #T_TEER in patients with #primary_TR? Check out this interview with @AtsushiSssugi discussing their #JACCINT manuscript
jacc.org/doi/10.1016/j.jcin.…
#CardioX #ACCFIT
2
29
3,824
Severe multiple valvular heart disease increases mortality after #TAVR, with tricuspid regurgitation posing the highest risk.
Read how staged transcatheter edge‐to‐edge repair improves outcomes. #AHAJournals @bara_doc @UniklinikBonn ahajrnls.org/44ohgX1
2
6
1,435
Baravan Al-Kassou | MD retweeted
11 Mar 2025
🎙️NEW #CRT2025 Interview 💫@bara_doc discusses insights from the GUARD study on the progression and outcomes of mild to moderate #aortic #stenosis.
📽️Watch here👉 ow.ly/qKqK50VfTz9
#CardioEd #CardioTwitter
3
7
825
11 Mar 2025
Fantastic keynote at #CRT2025 by @GeoffMartha, Chairman & CEO of #Medtronic, on the challenges & opportunities for Health Tech companies in this uncertain time of change.
Even on the last day, the main arena is packed with engaged & motivated attendees. @CRT_meeting @Medtronic
1
7
420
11 Mar 2025
Prof @ronwaksman expressing heartfelt gratitude to the incredible @CRT_meeting organizing team, who received well-deserved applause from attendees!
A fantastic meeting and an unforgettable experience—thank you for making #CRT2024 a success! 👏🏼 #CRTTeam
1
6
379
6 Mar 2025
Honored to receive a Young Leadership invitation to attend the CRT Meeting 2025. Grateful for this opportunity and excited to engage with fellow leaders and experts at this prestigious event. Looking forward to insightful discussions and learning ahead!
@CRT_meeting #CRT2025
1
4
26
1,288
In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV
ALT Colchicine in Acute Myocardial Infarction A Research Summary based on Jolly SS et al. | 10.1056/NEJMoa2405922 | Published on November 17, 2024 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
43
114
18,346
Baravan Al-Kassou | MD retweeted
8 Dec 2024
Ihr forscht zum Thema interventionelle Kardiologie? ⬇️EURE CHANCE ⬇️
Noch bis morgen Euer Projekt für den Andreas-Grüntzig-Forschungspreis einreichen ✊
Alle Infos:
herzmedizin.de/fuer-aerzte-u…
@AGIKinterv @YoungDgk @DGK_org @Kardiophil @TSchneiderMD @KardiologieHH @bara_doc
5
19
2,871
Baravan Al-Kassou | MD retweeted
28 Nov 2024
SGLT2i can reduce the incidence of new-onset diabetes among individuals with cardiovascular or kidney disease. Read more in #EHJ 👉 bit.ly/4eMWqTe
@RoccoMontone @ehj_ed #diabetes
1
50
164
17,205
Baravan Al-Kassou | MD retweeted
26 Nov 2024
A tale of measured and predicted prosthesis-patient-mismatch #PPM after #TAVR - an analysis of the #IMPPACT TAVI registry by @HenningGuthoff just published in @JACCJournals #JACCInt, accompanied by an editorial of the godfather of PPM @PPibarot
bit.ly/3V93T8p
🧵(1/8)
3
10
25
4,189
Presented at #AHA24:
Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: nej.md/3Z5ECOD
ALT Kaplan–Meier analysis of the primary end point.
3
122
276
45,388
12 Nov 2024
Our latest publication @JAMACardio: We identified 17 #AorticStenosis specific genetic loci, including 5 novel loci. Serum #phosphate is a unique AS risk factor. Our findings reveal AS's distinct pathways from #CAD, paving the way for targeted therapies.
➡️bit.ly/4ezb2pq
6
26
1,993
Baravan Al-Kassou | MD retweeted
7 Oct 2024
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
538
11,254
27,507
4,691,073
Baravan Al-Kassou | MD retweeted
3 Oct 2024
Hospitation im Hybrid-Op bei einer #TAVI? 🤩🫀
Von Zugangsweg über Prothesenpräparation bis hin zum Verschlusssystem 👀
Alles eine Frage des #Teamwork 🤝
Hier gibt es das ganze Video: youtu.be/Vtb9CuOY1CA?si=Cz_V…
@AtsushiSssugi @bara_doc @MAlZaidi_ @AndreasZietzer @HubrichtD
2
20
4,382
Baravan Al-Kassou | MD retweeted
2 Oct 2024
Among various #myocarditis diagnostic criteria, ESC criteria for clinically suspected myocarditis and updated Lake Louise criteria had the highest prognostic value. bit.ly/4eKsVSl
#JACC @chrisgraeni
5
67
189
23,278
27 Sep 2024
Spannende Session auf den #DGKHerztage|n zur #TAVI Nachsorge – von paravalvulärer Insuffizienz bis hin zu Schrittmacherstrategien und Endokarditis nach TAVI. 💡
Wertvolle Einblicke von Top-Experten!
@AGIKinterv @DGK_org @EPTIG @KardiologieHH
3
14
682
27 Sep 2024
Toller Vortrag 🔥 mit hilfreichen Einblicken und praktischen Tipps von @ElenaRepges am @YoungDgk Stand über die Strukturierung eines Abstracts!
Großer Andrang und großes Interesse der Anwesenden.
#DGKHerztage @DGK_org
1
4
19
787
Baravan Al-Kassou | MD retweeted
27 Sep 2024
Der zweite Showtag @DGK_org kann beginnen! Auf dem Programm stehen 1️⃣6️⃣ spannende @AGIKinterv Sessions:
🔥 4️⃣ Workshops 📍Saal C
🔥 2️⃣ Sessions speziell für Assistenzpersonal 📍Saal X1
🔥 3️⃣ AGIK Cinema-Sessions📍Saal X3
🔥 7️⃣ interessante Sessions 📍Saal G1 und Saal 3
6
11
669